Physician

Rajbinderpal Gill

According to 2025 Medicare claims, Rajbinderpal Gill (NPI: 1487688164) practices internal medicine in the Lexington Park, MD market, with the plurality of this provider's patient population coming from St. Marys, MD. This provider's primary affiliated billing organization is MEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC (NPI: 1831592211; TIN: 462691028) and primary practice location at 20650-0664.

Gill's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 724 traditional Medicare patients, billed 11,836 HCPCS/CPT codes, and received $389,906 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,875 prescription claims across 558 beneficiaries totaling $582,575 in drug costs, led by Eliquis (Apixaban). DME data shows 99 claims. Open Payments data shows 24 records totaling $699. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Similarly, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $44,841 to $5,313.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	988	13,038	$501,157
2016	965	13,908	$544,894
2017	956	12,868	$495,526
2018	921	13,307	$543,273
2019	897	13,046	$530,965
2020	761	9,580	$338,613
2021	768	12,065	$503,467
2022	790	12,477	$456,354
2023	735	11,181	$404,628
2024	724	11,836	$389,906

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	466	6,963	$615,066
2016	466	7,605	$695,442
2017	458	7,369	$721,041
2018	412	6,785	$640,617
2019	420	6,813	$679,451
2020	393	6,591	$636,199
2021	383	6,226	$627,363
2022	396	5,812	$600,176
2023	401	5,918	$498,949
2024	558	7,875	$582,575

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	401	1,069	$33,716
2016	358	1,011	$24,643
2017	159	559	$15,425
2018	157	520	$15,964
2019	127	360	$8,899
2020	85	430	$18,217
2021	70	348	$14,053
2022	28	261	$19,995
2023	22	166	$10,620
2024	16	99	$4,508

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	684	2,383	$57
80061	Blood test, lipids (cholesterol and triglycerides)	541	912	$13
80053	Blood test, comprehensive group of blood chemicals	547	944	$10
36415	Insertion of needle into vein for collection of blood sample	582	1,110	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	530	846	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	78	5,160	$96,552
Ozempic	Semaglutide	64	2,220	$70,852
Januvia	Sitagliptin Phosphate	44	3,300	$48,212
Xarelto	Rivaroxaban	13	1,170	$20,372
Jardiance	Empagliflozin	15	940	$18,302

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$2,096
B4036	Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	11	$1,281
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	16	41	$528
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	11	$389
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$201

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$699	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajbinderpal Gill?

Tedicare shows public-source Medicare data for Rajbinderpal Gill (NPI 1487688164), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajbinderpal Gill have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rajbinderpal Gill?

Rajbinderpal Gill is linked to MEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC (billing NPI 1831592211) in the available physician profile data.

Does Rajbinderpal Gill have Open Payments data?

Rajbinderpal Gill has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.